Breast cancer screenings should start at age 40 instead of 50, U.S. panel says

The U.S. Preventive Services Task Force said its new guidance on breast cancer screening could save 19% more lives.

Gilead Sciences defeats U.S. government lawsuit alleging HIV drug patent violations

The U.S. government had accused Gilead Science of violating patents for drugs used in the HIV prevention regimen PrEP.

Under Armour coped with higher promotions in the quarter, which weighed on profit margins.